**Intratympanic Steroid Treatment in Méniére Disease**

Fatih Oghan, Ibrahim Erdim, Metin Çeliker, Muhammet Fatih Topuz, Ahmet Uluat, Onur Erdogan and Sinan Aksoy

Additional information is available at the end of the chapter

http://dx.doi.org/10.5772/intechopen.69665

#### **Abstract**

[21] Sakashita T, Minowa Y, Hachikawa K. Evoked otoacoustic emissions from ears with idiopathic sudden deafness. Acta Otolaryngologica Supplementum. 1991;**486**:66‐72 [22] She W, Dai Y, Du X, Chen F, et al. Treatment of subjective tinnitus: A comparative clinical study of intratympanic steroid injection vs. oral carbamazepine. Medical Science

[23] Choi SJ, Lee JB, Lim HJ, In SM, et al. Intratympanic dexamethasone injection for refractory tinnitus: Prospective placebo‐controlled study. Laryngoscope. 2013;**123**(11):2817‐2822

[24] Yoshida T, Teranishi M, Iwata T, Otake H, et al. Intratympanic injection of dexamethasone for treatment of tinnitus in patients with sudden sensorineural hearing loss*.* Audiol

[25] Rah YC, Park KT, Yi YJ, Seok J, et al. Successful treatment of sudden sensorineural hearing loss assures improvement of accompanying tinnitus. The Laryngoscope.

[26] Ishida IM, Sugiura M, Teranishi M, Katayama M, et al. Otoacoustic emissions, ear fullness and tinnitus in the recovery course of sudden deafness. Auris Nasus Larynx.

[27] Canale A, Lacilla M, Giordano C, De Sanctis A, et al. The prognostic value of the otoacoustic emission test in low frequency sudden hearing loss. European Archives of

[28] Hoth S. On a possible prognostic value of otoacoustic emissions: A study on patients with sudden hearing loss. European Archives of Otorhinolaryngology. 2006;**262**(3):217‐224

[29] Schweinfurth JM, Cacace AT, Parnes SM. Clinical applications of otoacoustic emissions

[30] Chao TK, Chen THH. Distortion product otoacoustic emissions as a prognostic factor for idiopathic sudden sensorineural hearing loss. Audiology and Neurotology.

[31] Shupak A, Zeidan R, Shemesh R. Otoacoustic emissions in the prediction of sudden sen-

[32] Ben‐David J, Luntz M, Magamsa I, Fradis M, et al. Tinnitus as a prognostic sign in idiopathic sudden sensorineural hearing loss. The International Tinnitus Journal.

[33] An YH, Kyu KK, Kwak MY, Yoon SW, et al. Prognostic factors for the outcomes of intratympanic dexamethasone in the treatment of acute subjective tinnitus. Otology &

[34] Sakata T, Esaki Y, Yamano T, Sueta N, et al. A comparison between the feeling of ear fullness and tinnitus in acute sensorineural hearing loss. International Journal of Audiology.

sorineural hearing loss outcome. Otology & Neurotology. 2014;**10**:1‐7

Monitor. 2009;**15**:35‐39

186 Up to Date on Meniere's Disease

Research. 2012;**2**(1):4‐7

2015;**125**:1433‐1437

Otorhinolaryngology. 2005;**262**:208‐212

in sudden hearing loss. Laryngoscope. 1997;**107**:1457‐1463

2008;**35**:41‐46

2006;**11**:331‐338

2001;**7**(1):62‐64

2008;**47**(3):134‐140

Neurotology. 2014;**35**:1330‐1337

Méniére disease (MD) is characterized by vertigo attacks, hearing loss, tinnitus, and aural fullness. Although the exact treatment of MD is lacking, several treatment options including conservative, medical, and surgical aim to control symptoms. Recently, an increasingly used treatment method called intratympanic steroid (ITS) treatment is applied to patients suffering from MD. In which step the ITS takes part for MD treatment protocol is not certain. But common wisdom is that ITS can be used in patients with intractable MD to conservative and medical treatment before applying intratympanic gentamicin and surgical treatments.

**Keywords:** Méniére Disease, Steroid Treatment, Vertigo

#### **1. Introduction**

Méniére disease (MD) is characterized by vertigo attacks, hearing loss, tinnitus, and aural fullness. Several treatment options include conservative, medical, and surgical aims to control symptoms. Recently, an increasingly used treatment method called intratympanic steroid (ITS) treatment is applied to patients suffering from MD. In this chapter, we mention this alternative treatment option.
